Posted on 06th March 2012
Two patients in the US and one Briton were operated on as part of a global trial by US biotech firm ‘Advanced Cell Technology’ carried out at Moorfields Eye Hospital. Although promising, the researchers said such treatments could still be 10 years away from being available on the NHS.
22nd April 2021
After a year like no other, we are especially impressed by our optometrist, Rebecca Daly, who is one of the first individuals to have gained the NHS Education for Scotland Glaucoma Award Training (NES...Read more
14th April 2021
Myopia is expected to affect 50% of the world population by 2050. In the UK, the amount of myopia has increased from 10% to 23% of children in the past 50 years. In the past year, we have noticed an i...Read more